The Nutshell

» funding and cancer

Daily News Roundup

Most Recent

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Annually, about 184,000 deaths annually are linked to drinking sugary beverages, according to a new study.

7 Comments

image: The Cost of Irreproducible Research

The Cost of Irreproducible Research

By | June 10, 2015

Half of basic science studies cannot be replicated, according to a new analysis—to the tune of $28 billion a year in the U.S.

5 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

image: Viral Immunotherapy for Melanoma

Viral Immunotherapy for Melanoma

By | May 28, 2015

Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.

0 Comments

image: Targeting Protein Domains with CRISPR

Targeting Protein Domains with CRISPR

By | May 13, 2015

Researchers use the genome-editing tool to mutate binding pockets and identify potential anti-cancer drug targets.

0 Comments

image: Organoid Biobank

Organoid Biobank

By | May 11, 2015

From the tissue of numerous colon cancer patients, researchers build 3-D cultures of tumors.

0 Comments

image: Prominent Cell Biologist Dies

Prominent Cell Biologist Dies

By | May 4, 2015

Cytoskeleton specialist Alan Hall was best known for unpacking the roles of Rho GTPases.   

0 Comments

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Stroke Alters Gut Microbiome, Impacting Recovery
  4. Your Office Has a Distinct Microbiome
RayBiotech